Friday Agenda

To see more information about speakers click here.

Cancer in Our Lives: Raising Awareness in the LGBTQI Community


Friday, October 13, 2006

Health Professionals Focus on Cancer

Part of the 24th annual conference of the Gay and Lesbian Medical Association

Renaissance Parc 55 Hotel



9:00 – 10:00   



10:00 – 10:15 

Welcome remarks

David Veneziano, CEO, American Cancer Society, California Division


Appreciations and “Cancer Symposium” Introduction

 J. Michael Berry, M.D.


10:15 – 11:00 

Plenary panel:

Putting a Face on Cancer in the LGBTQI Community



Four cancer survivors and members of the LGBTQI community will share their personal stories of cancer.  Dr. Michael Berry will provide a corresponding brief overview of the state of knowledge regarding the particular cancer and risk and screening as it relates to the LGBTQI community.  The goal is to put a human face on cancer as it occurs in our community emphasizing the need for further LGBTQI specific research into risk factors unique to the LGBTQI community and how cancer impacts our community, setting the stage for more in depth discussion to follow in the afternoon sessions . 


Moderator: J. Michael Berry, M.D.

LGBTQI Cancer Survivor Representatives



11:00 – 11:45 


Hope for the Future: A Vaccine to Prevent Cervical Cancer

 Presenter: Eliav Barr, MD



Human papillomavirus (HPV) infection is the most common sexually transmitted infection in the world. Manifestations range from genital warts to precancerous lesions of the cervix and anus to cervical and anal cancer.

Dr. Eliav Barr from Merck will discuss the Phase 3 trials of Gardasil, an preventative vaccine against HPV 6, 11, 16, and 18, four HPV types that cause the majority of HPV-related disease worldwide. The vaccine was highly effective in preventing high-grade cervical pre-cancer and non-invasive cervical cancer caused by HPV 16 and HPV 18 as well as genital warts caused by HPV 6 and HPV 11. The vaccine is currently being evaluated as a preventative for penile HPV infection in young heterosexual men and because of Dr. Barr's advocacy, a trial evaluating the efficacy of the vaccine in preventing anal and penile infection in young gay men is underway.

On June 8, 2006, the FDA approved Gardasil for use in girls and women aged 9 to 26 years for prevention of cervical cancer, precancerous lesions, and genital warts caused by vaccine HPV types. This vaccine holds great hope for the future for both men and women.

11:45 – 1:00   

Hosted Luncheon/Exhibits

Brief announcements



1:00 – 2:30

Plenary panel:

HIV-Related Cancers, Anal Cancer, and Cancers Affecting Lesbians, Bisexual Women



This session will provide an overview to clinicians and researchers of HIV-related cancers regardless of gender, anal cancer and cancers affective lesbians and bisexual women.


Moderator: David M. Latini, Ph.D


HIV-Related Cancers 

Presenter: Vinona Bhatia, MD  


Update on Anal Cancer Screening & Treatment

Presenter: J. Michael Berry, M.D. & Stephen E. Goldstone, M.D.


Breast Cancer & Lesbian and Bisexual Women

Presenter: Ulrike Boehmer, Ph.D.

Gynecologic Cancers in Lesbian and Bisexual Women

Presenter: Katherine A. O’Hanlan, M.D. and Suzanne L. Dibble DNSc, RN


2:30 – 3:00      



3:00 – 4:30      

Plenary panel: Cancers Affecting Intersex and Transfolks, Prostate Cancer in Gay Men and "Cancer Symposium Summary"



This session will provide an overview to clinicians and researchers of cancers primarily affecting the intersex and trans communities and prostate cancer.  The last speaker will provide an overview and summing up of what we’ve learned today and how we can move forward to alleviate the burden of cancer in the LGBTQI communities.


Moderator: David M. Latini, Ph.D.

Cancer and Intersex People

Presenter: Katherine Baratz, M.A.

 Cancer and Trans Individuals

Presenter: Milton Diamond, Ph.D.

Prostate Cancer and Gay Men
Presenter: Mark S. Litwin, M.D., M.P.H.


Summary/ Overview and Next Steps

Presenter: Ronit Elk, Ph.D.



To see more information about speakers click here.